financetom
Business
financetom
/
Business
/
Morgan Stanley's wealth arm under probe by multiple regulators, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Morgan Stanley's wealth arm under probe by multiple regulators, WSJ reports
Apr 11, 2024 11:52 AM

(Reuters) - Investment bank Morgan Stanley's ( MS ) wealth management arm is being probed by multiple regulators, the Wall Street Journal reported on Thursday citing people familiar with the matter.

The U.S. Securities and Exchange Commission, the Office of the Comptroller of the Currency (OCC) and other Treasury Department offices are involved, the report said. Shares of the bank fell 4.4% to $87.71.

Morgan Stanley's ( MS ) wealth management unit caters to high net-worth individuals and small to medium-sized businesses, providing them with brokerage, custody, investment advisory and financial planning services.

The business is more insulated from seismic shifts in the market compared to investment banking and has been a crucial factor in determining the premium valuation Morgan Stanley ( MS ) commands relative to rival Goldman Sachs.

The main issues under the scanner were whether the bank has been sufficiently investigating the identities of prospective clients and where their wealth comes from, and how it monitors their financial activity, the report said.

Some of the probes are also focusing on international clients, the report added.

Morgan Stanley ( MS ) had only recently resolved a years-long investigation into its block trading practices.

Spokespeople for Morgan Stanley ( MS ), the SEC, the OCC and the Treasury did not immediately respond to Reuters' requests for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Morgan Stanley's wealth arm under probe by multiple regulators, WSJ reports
Morgan Stanley's wealth arm under probe by multiple regulators, WSJ reports
Apr 11, 2024
(Reuters) - Investment bank Morgan Stanley's ( MS ) wealth management arm is being probed by multiple regulators, the Wall Street Journal reported on Thursday citing people familiar with the matter. The U.S. Securities and Exchange Commission, the Office of the Comptroller of the Currency (OCC) and other Treasury Department offices are involved, the report said. Shares of the bank...
Boeing focused on 'trust building' in Latin America after global CEO shake-up
Boeing focused on 'trust building' in Latin America after global CEO shake-up
Apr 11, 2024
SANTIAGO, April 11 (Reuters) - Boeing's ( BA ) Latin America President Landon Loomis says that the embattled airplane manufacturer is focusing on rebuilding trust after a series of safety incidents have shaken trust in the company and led CEO Dave Calhoun to announce he would step down by year-end. We are in the moment of a deep fundamental trust...
Boeing focused on 'trust building' in Latin America after global CEO shake-up
Boeing focused on 'trust building' in Latin America after global CEO shake-up
Apr 11, 2024
SANTIAGO (Reuters) - Boeing's ( BA ) Latin America President Landon Loomis says that the embattled airplane manufacturer is focusing on rebuilding trust after a series of safety incidents have shaken trust in the company and led CEO Dave Calhoun to announce he would step down by year-end. We are in the moment of a deep fundamental trust building exercise...
Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment
Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment
Apr 11, 2024
02:28 PM EDT, 04/11/2024 (MT Newswires) -- Ocuphire Pharma ( OCUP ) enrolled the first patient in the phase 3 trial of its Phentolamine Ophthalmic Solution 0.75% for the treatment of decreased visual acuity under low light conditions following keratorefractive surgery, the company said Thursday. The trial is conducted under the US Food and Drug Administration's Special Protocol Assessment, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved